Organicell Regenerative Medicine, Inc. Closes $5.5 Million Funding Round
Aug 26, 2022•almost 3 years ago
Amount Raised
$5.5 Million
Description
MIAMI, FL / August 26, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focused on the development of innovative regenerative medicine and biological therapeutics, has closed its previously announced $4.0 million capital raise at $0.02 and corporate restructuring transaction. Organicell also closed on an additional $1.5 million of funding at $0.04 per share from two additional investors, totaling $5.5 million in funding.